AlexeyDanilovMD

Summary

• I earned my medical degree and PhD at Yaroslavl State Medical Academy in Russia and completed a fellowship in hematology/oncology at Tufts Medical Center, in Boston, Massachusetts. I am a physician-scientist with background in molecular biology and oncologic drug development and expertise in cancer cell signaling. I lead an independent research program in hematologic malignancies which bridges the understanding of blood cancer biology with early clinical evaluation of novel therapeutics.
  
  As a leader of the Lymphoma Center at the City of Hope National Medical Center, I guide an effort in experimental therapeutics in lymphoid malignancies. In addition to pre-clinical focus on evaluation of novel targets in the ubiquitin-proteasome system (1) and oncogenic role of cyclin-dependent kinase-9 (2), my group performs correlative science on multiple clinical trials. I received peer-reviewed funding from the National Cancer Institute, Leukemia and Lymphoma Society, American Society of Hematology, Lymphoma Research Foundation and SWOG, and serve as Translational Medicine Chair at SWOG Lymphoma Committee.
  Clinically, I am a practicing medical oncologist specializing in the care of patients with CLL and lymphoma. Building on our group's pre-clinical discoveries, we launched multiple early-phase clinical trials with novel agents targeting Nedd8-activating enzyme, BTK, PI3K and SYK. As a member of industry and SWOG committees, I participate in drug development on a global scale.